Preliminary Evidence of Efficacy and Target Engagement of Pramipexole in Anhedonic Depression
Psychiatric Research and Clinical Practice · 2022-06 · 4 (2) · 42-47
DOI: 10.1176/appi.prcp.20210042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychiatric Research and Clinical Practice, 2022-06. Verfasst von Filip Ventorp und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences Lund, Psychiatry, Faculty of Medicine Lund University Lund Sweden. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Depression
Abstract (Originalsprache)
Objective
To investigate feasibility and target engagement of high-dose, add-on pramipexole treatment in anhedonic depression.
Method
In this open-label pilot study, we included 12 patients with unipolar or bipolar, moderate-to-severe depression and with significant anhedonia symptoms. All patients were on a stable dose of one or a combination of antidepressants and/or mood stabilizers and received 10 weeks of adjunctive pramipexole titrated to a maximum dose of 4.5 mg salt/day. All patients were rated with the Dimensional Anhedonia Rating Scale (DARS), the Montgomery Åsberg Depression Rating (MADRS) and the Snaith Hamilton Pleasure Scale (SHAPS). Serum high-sensitivity C-reactive protein (hs-CRP) was analyzed pre- and post-treatment. Eight patients underwent fMRI pre- and post-treatment and a simplified version of the monetary incentive delay task was used to investigate the effect of treatment on striatal activity during reward anticipation.
Results
DARS, MADRS and SHAPS scores all improved significantly over 10 weeks of pramipexole treatment (p
Autor:innen und Institutionen
- Department of Clinical Sciences Lund, Psychiatry, Faculty of Medicine Lund University Lund Sweden.
- Office for Psychiatry and Habilitation, Psychiatric Clinic Lund Lund Sweden.
- Department of Clinical Sciences Lund, Diagnostic Radiology, Faculty of Medicine Lund University Lund Sweden.
- Image and Function Skåne University Hospital Lund Sweden.
- Centre for Psychology Kristianstad University Kristianstad Sweden.
- Department of Psychology Lund University Lund Sweden.
Zitieren
APA
Ventorp, F., Lindahl, J., van Westen, D., Jensen, J., Björkstrand, J., & Lindqvist, D. (2022). Preliminary Evidence of Efficacy and Target Engagement of Pramipexole in Anhedonic Depression. Psychiatric Research and Clinical Practice, 4(2), 42-47. https://doi.org/10.1176/appi.prcp.20210042
Vancouver
Ventorp F, Lindahl J, van Westen D, Jensen J, Björkstrand J, Lindqvist D. Preliminary Evidence of Efficacy and Target Engagement of Pramipexole in Anhedonic Depression. Psychiatric Research and Clinical Practice. 2022;4(2):42-47. doi:10.1176/appi.prcp.20210042
BibTeX
@article{Ventorp2022,
author = {Ventorp, Filip and Lindahl, Jesper and van Westen, Danielle and Jensen, Jimmy and Björkstrand, Johannes and Lindqvist, Daniel},
title = {Preliminary Evidence of Efficacy and Target Engagement of Pramipexole in Anhedonic Depression},
journal = {Psychiatric Research and Clinical Practice},
year = {2022},
volume = {4},
number = {2},
pages = {42--47},
doi = {10.1176/appi.prcp.20210042}
}
EUVIMED